Aridis Pharmaceuticals In... (ARDS)
OTC: ARDS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM
Aridis Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -83K | 12.14M | -6.82M | -6.39M | -8.24M | -7.98M | -7.77M | -8.81M | -21M | -5.49M | -6.89M |
Depreciation & Amortization | 59K | 63K | 87K | 100K | 125K | 131K | 131K | 157K | 94K | 93K | 91K |
Stock-Based Compensation | 200K | 210K | 245K | 318K | 349K | 345K | 467K | 551K | 580K | 553K | 567K |
Other Working Capital | -791K | -19.45M | -1.07M | 1.25M | 3K | 1.53M | -1.15M | 2.26M | 6.15M | -501K | 955K |
Other Non-Cash Items | 676K | 69K | 605K | -921K | 823K | 276K | 366K | 283K | 6.46M | -722K | 33K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 33K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.83M | -16.83M | 1.88M | -1.67M | 2.68M | 1.05M | -3.36M | 4.09M | 5.28M | -1.04M | 2.19M |
Operating Cash Flow | -983K | -4.34M | -4M | -8.56M | -4.26M | -6.14M | -10.17M | -3.73M | -8.59M | -6.61M | -4.01M |
Capital Expenditures | n/a | n/a | n/a | -49K | n/a | -12K | -21K | 43K | -114K | -124K | -335K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 14K | n/a | -49K | n/a | -12K | -21K | 43K | -114K | -124K | -335K |
Debt Repayment | -735K | 3.23M | -1.49M | -1.35M | -450K | n/a | 5M | 5M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.13M | n/a | n/a | n/a |
Other Financial Acitivies | -3K | -208K | -308K | -227K | -104K | -139K | -557K | 4.13M | n/a | 5K | n/a |
Financial Cash Flow | 999K | 3.03M | 263K | 11.03M | -554K | -139K | 4.44M | 4.95M | 23.34M | -149K | 6.58M |
Net Cash Flow | 16K | -1.3M | -3.74M | 2.43M | -4.82M | -6.29M | -5.74M | 1.26M | 14.63M | -6.88M | 2.24M |
Free Cash Flow | -983K | -4.34M | -4M | -8.61M | -4.26M | -6.15M | -10.19M | -3.69M | -8.71M | -6.73M | -4.34M |